OMNIPAQUE
- Product NDC
- 71872-7370
- Requested package NDC
- 71872-7370-1
- 11-digit product format
- 718727370
- Labeler code
- 71872
- Product ID
- 71872-7370_508c3891-4ffc-31df-e063-6394a90a99b6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Iohexol
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRA-ARTICULAR; INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL; RECTAL
- Labeler
- Medical Purchasing Solutions, LLC
- Application
- NDA018956
- Marketing category
- NDA
- Marketing start
- 1985-12-26
- Substance
- IOHEXOL
- Active strength
- 300 mg/mL
- Pharmacologic classes
- Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018956-001 | OMNIPAQUE 180 | IOHEXOL | 38.8% | SOLUTION / INJECTION, ORAL, RECTAL | RLD, RS | 1985-12-26 | |
| N018956-002 | OMNIPAQUE 240 | IOHEXOL | 51.8% | SOLUTION / INJECTION, ORAL, RECTAL | RLD, RS | 1985-12-26 | |
| N018956-003 | OMNIPAQUE 300 | IOHEXOL | 64.7% | SOLUTION / INJECTION, ORAL, RECTAL | AP | RLD, RS | 1985-12-26 |
| N018956-004 | OMNIPAQUE 350 | IOHEXOL | 75.5% | SOLUTION / INJECTION, ORAL | AP | RLD, RS | 1985-12-26 |
| N018956-005 | OMNIPAQUE 140 | IOHEXOL | 30.2% | INJECTABLE / INJECTION | RLD, RS | 1988-11-30 | |
| N018956-006 | OMNIPAQUE 210 | IOHEXOL | 45.3% | INJECTABLE / INJECTION | 1989-06-30 | ||
| N018956-007 | OMNIPAQUE 70 | IOHEXOL | 15.1% | SOLUTION / URETHRAL | 1994-06-01 | ||
| N018956-008 | OMNIPAQUE 9 | IOHEXOL | 1.9% | SOLUTION / ORAL | RLD, RS | 2018-04-17 | |
| N018956-009 | OMNIPAQUE 12 | IOHEXOL | 2.6% | SOLUTION / ORAL | RLD, RS | 2018-04-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N018956-003 | AP |
| N018956-004 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N018956-001 | OMNIPAQUE 180 | 38.8% | SOLUTION / INJECTION, ORAL, RECTAL | RLD, RS | 1985-12-26 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N018956-002 | OMNIPAQUE 240 | 51.8% | SOLUTION / INJECTION, ORAL, RECTAL | RLD, RS | 1985-12-26 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N018956-003 | OMNIPAQUE 300 | 64.7% | SOLUTION / INJECTION, ORAL, RECTAL | AP | RLD, RS | 1985-12-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N018956-004 | OMNIPAQUE 350 | 75.5% | SOLUTION / INJECTION, ORAL | AP | RLD, RS | 1985-12-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N018956-005 | OMNIPAQUE 140 | 30.2% | INJECTABLE / INJECTION | RLD, RS | 1988-11-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N018956-006 | OMNIPAQUE 210 | 45.3% | INJECTABLE / INJECTION | 1989-06-30 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N018956-007 | OMNIPAQUE 70 | 15.1% | SOLUTION / URETHRAL | 1994-06-01 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N018956-008 | OMNIPAQUE 9 | 1.9% | SOLUTION / ORAL | RLD, RS | 2018-04-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N018956-009 | OMNIPAQUE 12 | 2.6% | SOLUTION / ORAL | RLD, RS | 2018-04-17 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N018956-001 | OMNIPAQUE 180 | 38.8% | SOLUTION / INJECTION, ORAL, RECTAL | RLD, RS | 1985-12-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N018956-002 | OMNIPAQUE 240 | 51.8% | SOLUTION / INJECTION, ORAL, RECTAL | RLD, RS | 1985-12-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N018956-003 | OMNIPAQUE 300 | 64.7% | SOLUTION / INJECTION, ORAL, RECTAL | AP | RLD, RS | 1985-12-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N018956-004 | OMNIPAQUE 350 | 75.5% | SOLUTION / INJECTION, ORAL | AP | RLD, RS | 1985-12-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N018956-005 | OMNIPAQUE 140 | 30.2% | INJECTABLE / INJECTION | RLD, RS | 1988-11-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N018956-006 | OMNIPAQUE 210 | 45.3% | INJECTABLE / INJECTION | 1989-06-30 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018956-007 | OMNIPAQUE 70 | 15.1% | SOLUTION / URETHRAL | 1994-06-01 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018956-008 | OMNIPAQUE 9 | 1.9% | SOLUTION / ORAL | RLD, RS | 2018-04-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N018956-009 | OMNIPAQUE 12 | 2.6% | SOLUTION / ORAL | RLD, RS | 2018-04-17 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N018956-001 | OMNIPAQUE 180 | 38.8% | SOLUTION / INJECTION, ORAL, RECTAL | RLD, RS | 1985-12-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N018956-002 | OMNIPAQUE 240 | 51.8% | SOLUTION / INJECTION, ORAL, RECTAL | RLD, RS | 1985-12-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N018956-003 | OMNIPAQUE 300 | 64.7% | SOLUTION / INJECTION, ORAL, RECTAL | AP | RLD, RS | 1985-12-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N018956-004 | OMNIPAQUE 350 | 75.5% | SOLUTION / INJECTION, ORAL | RLD, RS | 1985-12-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N018956-005 | OMNIPAQUE 140 | 30.2% | INJECTABLE / INJECTION | RLD, RS | 1988-11-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N018956-006 | OMNIPAQUE 210 | 45.3% | INJECTABLE / INJECTION | 1989-06-30 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018956-007 | OMNIPAQUE 70 | 15.1% | SOLUTION / URETHRAL | 1994-06-01 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018956-008 | OMNIPAQUE 9 | 1.9% | SOLUTION / ORAL | RLD, RS | 2018-04-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N018956-009 | OMNIPAQUE 12 | 2.6% | SOLUTION / ORAL | RLD, RS | 2018-04-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018956-001 | OMNIPAQUE 180 | 38.8% | SOLUTION / INJECTION, ORAL, RECTAL | RLD, RS | 1985-12-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018956-002 | OMNIPAQUE 240 | 51.8% | SOLUTION / INJECTION, ORAL, RECTAL | RLD, RS | 1985-12-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018956-003 | OMNIPAQUE 300 | 64.7% | SOLUTION / INJECTION, ORAL, RECTAL | AP | RLD, RS | 1985-12-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018956-004 | OMNIPAQUE 350 | 75.5% | SOLUTION / INJECTION, ORAL | RLD, RS | 1985-12-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018956-005 | OMNIPAQUE 140 | 30.2% | INJECTABLE / INJECTION | RLD, RS | 1988-11-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018956-006 | OMNIPAQUE 210 | 45.3% | INJECTABLE / INJECTION | 1989-06-30 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018956-007 | OMNIPAQUE 70 | 15.1% | SOLUTION / URETHRAL | 1994-06-01 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018956-008 | OMNIPAQUE 9 | 1.9% | SOLUTION / ORAL | RLD, RS | 2018-04-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018956-009 | OMNIPAQUE 12 | 2.6% | SOLUTION / ORAL | RLD, RS | 2018-04-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N018956-001 | OMNIPAQUE 180 | 38.8% | SOLUTION / INJECTION, ORAL, RECTAL | RLD, RS | 1985-12-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N018956-002 | OMNIPAQUE 240 | 51.8% | SOLUTION / INJECTION, ORAL, RECTAL | RLD, RS | 1985-12-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N018956-003 | OMNIPAQUE 300 | 64.7% | SOLUTION / INJECTION, ORAL, RECTAL | RLD, RS | 1985-12-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N018956-004 | OMNIPAQUE 350 | 75.5% | SOLUTION / INJECTION, ORAL | RLD, RS | 1985-12-26 | 6a471c1ec25d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N018956-003 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N018956-004 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N018956-003 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N018956-004 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N018956-003 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018956-003 | AP | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N018956-003 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N018956-004 | AP | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- OMNIPAQUE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| IOHEXOL | 300 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4419T9MX03 | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 508c42eb-f5e5-44f1-e063-6294a90a4d1f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 77dc03a4-fbfc-e6a3-fe95-285bbae40d75 | Product name | 2 | 20250814 |
| 777d68c6-a5ab-e06c-d314-677b0b9af0c8 | Product name | 2 | 20240508 |
| 5f30b278-5791-4113-8781-878a9221ef8a | Product name | 2 | 20230125 |
| 2a70c781-a755-4d76-b20a-a958acfbdcdc | Product name | 2 | 20190619 |
| 304592ef-4a8a-4c22-8e8c-af73aa3d60e5 | Product name | 1 | 20180703 |
| ac0821a1-ce75-4ea7-880a-59eecaecdf22 | Product name | 1 | 20180703 |
| db5dc4f9-b907-46f6-8fb7-babcf04bbe5c | Product name | 1 | 20180619 |
| 41e9d6cf-3ed7-4c44-a57e-0685058d0896 | Product name | 1 | 20170824 |
| 5e652c92-68fd-426b-b0e7-5fc64e0b9f99 | Product name | 1 | 20170309 |
| ddc0c11a-bba8-408f-b3c7-c4828b4bcc8c | Product name | 1 | 20150421 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71872-7370-1 | OMNIPAQUE | 1 in 1 BAG | INJECTION, SOLUTION | 1 | 1 | |
| 71872-7370-1 | OMNIPAQUE | 30 mL in 1 BOTTLE, PLASTIC | INJECTION, SOLUTION | 30 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OMNIPAQUE | IOHEXOL | Medical Purchasing Solutions, LLC | 5088be1d-a708-1cac-e063-6394a90a2aff | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | 018956 NDA018956 |
| OMNIPAQUE | IOHEXOL | Medical Purchasing Solutions, LLC | 508c42eb-f5e5-44f1-e063-6294a90a4d1f | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | 018956 NDA018956 71872-7370-1 71872-7370 71872737001 |
| OMNIPAQUE | IOHEXOL | GE Healthcare Inc. | eee15ebe-d349-4497-acef-6abe7a8247fb | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | 018956 NDA018956 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 71872-7370-1 | 71872737001 | 1 BOTTLE, PLASTIC in 1 BAG (71872-7370-1) / 30 mL in 1 BOTTLE, PLASTIC | 2026-03-26 | No | No | Current |